AIM ImmunoTech, Inc. (AIM)
0.2372
-0.01
(-2.59%)
USD |
NYAM |
May 22, 16:00
0.23
-0.01
(-3.04%)
After-Hours: 20:00
AIM ImmunoTech EPS Diluted (Quarterly) : -0.6947 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Curis, Inc. | -1.250 |
| Plus Therapeutics, Inc. | -1.045 |
| Windtree Therapeutics, Inc. | -1.085 |
| Halozyme Therapeutics, Inc. | 1.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.023M |
| Revenue (Quarterly) | 0.022M |
| Total Expenses (Quarterly) | 3.045M |
| Enterprise Value | -0.4977M |
| Gross Profit Margin (Quarterly) | -113.6% |
| Profit Margin (Quarterly) | -13.74K% |
| Earnings Yield | -3.08K% |
| Normalized Earnings Yield | -2885.67 |